Last reviewed · How we verify
Biotinylated Red Blood Cells
Biotinylated Red Blood Cells is a Small molecule drug developed by John A Widness. It is currently in Phase 2 development. Also known as: BioRBC.
At a glance
| Generic name | Biotinylated Red Blood Cells |
|---|---|
| Also known as | BioRBC |
| Sponsor | John A Widness |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion (PHASE1)
- Red Blood Cell Survival in Sickle Cell Disease (PHASE1)
- Effect of Red Blood Cell Survival on a Commonly Used Diabetes Lab Test-HbA1c (NA)
- Transfusion of Biotinylated Red Blood Cells (PHASE1)
- RBC Lifespan Measurement in Diabetic Children (PHASE1)
- Red Blood Cell (RBC) Survival Following Transfusion in Infants (PHASE2)
- BioRBC Survival in Adults With Prior Antibody Response to BioRBCs (PHASE1)
- Optimized Erythropoietin (EPO) Treatment (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Biotinylated Red Blood Cells CI brief — competitive landscape report
- Biotinylated Red Blood Cells updates RSS · CI watch RSS
- John A Widness portfolio CI
Frequently asked questions about Biotinylated Red Blood Cells
What is Biotinylated Red Blood Cells?
Biotinylated Red Blood Cells is a Small molecule drug developed by John A Widness.
Who makes Biotinylated Red Blood Cells?
Biotinylated Red Blood Cells is developed by John A Widness (see full John A Widness pipeline at /company/john-a-widness).
Is Biotinylated Red Blood Cells also known as anything else?
Biotinylated Red Blood Cells is also known as BioRBC.
What development phase is Biotinylated Red Blood Cells in?
Biotinylated Red Blood Cells is in Phase 2.
Related
- Manufacturer: John A Widness — full pipeline
- Also known as: BioRBC
- Compare: Biotinylated Red Blood Cells vs similar drugs
- Pricing: Biotinylated Red Blood Cells cost, discount & access